Reference
Tresman R, et al. Healthcare resource use and attributable cost of Clostridium difficile infection: a micro-costing analysis comparing first and recurrent episodes. Journal of Antimicrobial Chemotherapy : 2 Jul 2018. Available from: URL: http://doi.org/10.1093/jac/dky250
Rights and permissions
About this article
Cite this article
Substantial burden of C. difficile infection in the UK. PharmacoEcon Outcomes News 808, 30 (2018). https://doi.org/10.1007/s40274-018-5145-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5145-2